Skip to main content
Caplight Logo









Sylke

Sylke

Private
La Jolla, CaliforniaHealthcare & Life Scienceshttps://sylke.com

Last Round

Series A

Mar 1, 2025

Est. Valuation

$160.03M

Total Funding Raised

$15.53M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Sylke operates in Healthcare & Life Sciences and is based in La Jolla, California. Its latest recorded funding round was a Series A round in March 2025.

Sylke is a surgical devices company that has developed SYLKE™, a dressing made of pure hypoallergenic silk fibroin designed to enhance healing across surgical wounds.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, E-commerce

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Sylke Comparables

Compare Sylke with similar companies based on industry and business-model similarity.

Sylke comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Clozex Medical, Inc.
82%
BandGrip
79%
BRIJ Medical, Inc.
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Sylke Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 1, 2025
SeedAug 1, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Sylke Investors

Notable investors and investment history

Sylke investors
InvestorRounds
Vaark VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 79% MoM.

  • Feb 24, 2026

    Grew 48% QoQ, from 25 to 37 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Sylke Filings

Explore SEC and related filing metadata, where available.

Sylke filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Sylke's valuation, stock price, and market status.

Is Sylke a public or private company?

Sylke is a private company.

What is the current stock price of Sylke?

Sylke is a private company, so its shares have no public market price. Caplight tracks Sylke's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Sylke worth (valuation)?

Sylke's valuation is estimated at $160.0M based on funding round data.

Can I buy Sylke stock?

Sylke shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Sylke's last funding round?

Sylke's most recent funding round was Series A on March 1, 2025.

Who are the main investors in Sylke?

Key investors in Sylke include Vaark Ventures.

Will Sylke IPO soon?

No public IPO plans have been announced for Sylke.

How can I track Sylke secondary market activity?

Caplight tracks bids, offers, and trades in Sylke's shares on secondary markets.

Firmographic Details

HeadquartersLa Jolla, California
Employee Range34
Year Founded2022
Last FundingMar 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?